205 related articles for article (PubMed ID: 35830882)
1. Structure of the MRAS-SHOC2-PP1C phosphatase complex.
Hauseman ZJ; Fodor M; Dhembi A; Viscomi J; Egli D; Bleu M; Katz S; Park E; Jang DM; Porter KA; Meili F; Guo H; Kerr G; Mollé S; Velez-Vega C; Beyer KS; Galli GG; Maira SM; Stams T; Clark K; Eck MJ; Tordella L; Thoma CR; King DA
Nature; 2022 Sep; 609(7926):416-423. PubMed ID: 35830882
[TBL] [Abstract][Full Text] [Related]
2. Structure-function analysis of the SHOC2-MRAS-PP1C holophosphatase complex.
Kwon JJ; Hajian B; Bian Y; Young LC; Amor AJ; Fuller JR; Fraley CV; Sykes AM; So J; Pan J; Baker L; Lee SJ; Wheeler DB; Mayhew DL; Persky NS; Yang X; Root DE; Barsotti AM; Stamford AW; Perry CK; Burgin A; McCormick F; Lemke CT; Hahn WC; Aguirre AJ
Nature; 2022 Sep; 609(7926):408-415. PubMed ID: 35831509
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for SHOC2 modulation of RAS signalling.
Liau NPD; Johnson MC; Izadi S; Gerosa L; Hammel M; Bruning JM; Wendorff TJ; Phung W; Hymowitz SG; Sudhamsu J
Nature; 2022 Sep; 609(7926):400-407. PubMed ID: 35768504
[TBL] [Abstract][Full Text] [Related]
4. Structure of the SHOC2-MRAS-PP1C complex provides insights into RAF activation and Noonan syndrome.
Bonsor DA; Alexander P; Snead K; Hartig N; Drew M; Messing S; Finci LI; Nissley DV; McCormick F; Esposito D; Rodriguez-Viciana P; Stephen AG; Simanshu DK
Nat Struct Mol Biol; 2022 Oct; 29(10):966-977. PubMed ID: 36175670
[TBL] [Abstract][Full Text] [Related]
5. Structural insights into the role of SHOC2-MRAS-PP1C complex in RAF activation.
Bonsor DA; Simanshu DK
FEBS J; 2023 Oct; 290(20):4852-4863. PubMed ID: 37074066
[TBL] [Abstract][Full Text] [Related]
6. SHOC2-MRAS-PP1 complex positively regulates RAF activity and contributes to Noonan syndrome pathogenesis.
Young LC; Hartig N; Boned Del Río I; Sari S; Ringham-Terry B; Wainwright JR; Jones GG; McCormick F; Rodriguez-Viciana P
Proc Natl Acad Sci U S A; 2018 Nov; 115(45):E10576-E10585. PubMed ID: 30348783
[TBL] [Abstract][Full Text] [Related]
7. SHOC2 complex-driven RAF dimerization selectively contributes to ERK pathway dynamics.
Boned Del Río I; Young LC; Sari S; Jones GG; Ringham-Terry B; Hartig N; Rejnowicz E; Lei W; Bhamra A; Surinova S; Rodriguez-Viciana P
Proc Natl Acad Sci U S A; 2019 Jul; 116(27):13330-13339. PubMed ID: 31213532
[TBL] [Abstract][Full Text] [Related]
8. A Leucine-Rich Repeat Protein Provides a SHOC2 the RAS Circuit: a Structure-Function Perspective.
Kwon JJ; Hahn WC
Mol Cell Biol; 2021 Mar; 41(4):. PubMed ID: 33526449
[TBL] [Abstract][Full Text] [Related]
9. A phosphatase holoenzyme comprised of Shoc2/Sur8 and the catalytic subunit of PP1 functions as an M-Ras effector to modulate Raf activity.
Rodriguez-Viciana P; Oses-Prieto J; Burlingame A; Fried M; McCormick F
Mol Cell; 2006 Apr; 22(2):217-30. PubMed ID: 16630891
[TBL] [Abstract][Full Text] [Related]
10. An MRAS, SHOC2, and SCRIB complex coordinates ERK pathway activation with polarity and tumorigenic growth.
Young LC; Hartig N; Muñoz-Alegre M; Oses-Prieto JA; Durdu S; Bender S; Vijayakumar V; Vietri Rudan M; Gewinner C; Henderson S; Jathoul AP; Ghatrora R; Lythgoe MF; Burlingame AL; Rodriguez-Viciana P
Mol Cell; 2013 Dec; 52(5):679-92. PubMed ID: 24211266
[TBL] [Abstract][Full Text] [Related]
11. MRAS: A Close but Understudied Member of the RAS Family.
Young LC; Rodriguez-Viciana P
Cold Spring Harb Perspect Med; 2018 Dec; 8(12):. PubMed ID: 29311130
[TBL] [Abstract][Full Text] [Related]
12. SHOC2 phosphatase-dependent RAF dimerization mediates resistance to MEK inhibition in RAS-mutant cancers.
Jones GG; Del Río IB; Sari S; Sekerim A; Young LC; Hartig N; Areso Zubiaur I; El-Bahrawy MA; Hynds RE; Lei W; Molina-Arcas M; Downward J; Rodriguez-Viciana P
Nat Commun; 2019 Jun; 10(1):2532. PubMed ID: 31182717
[TBL] [Abstract][Full Text] [Related]
13. Clinical and functional characterization of a novel RASopathy-causing SHOC2 mutation associated with prenatal-onset hypertrophic cardiomyopathy.
Motta M; Giancotti A; Mastromoro G; Chandramouli B; Pinna V; Pantaleoni F; Di Giosaffatte N; Petrini S; Mazza T; D'Ambrosio V; Versacci P; Ventriglia F; Chillemi G; Pizzuti A; Tartaglia M; De Luca A
Hum Mutat; 2019 Aug; 40(8):1046-1056. PubMed ID: 31059601
[TBL] [Abstract][Full Text] [Related]
14. Activating MRAS mutations cause Noonan syndrome associated with hypertrophic cardiomyopathy.
Motta M; Sagi-Dain L; Krumbach OHF; Hahn A; Peleg A; German A; Lissewski C; Coppola S; Pantaleoni F; Kocherscheid L; Altmüller F; Schanze D; Logeswaran T; Chahrokh-Zadeh S; Munzig A; Nakhaei-Rad S; Cavé H; Ahmadian MR; Tartaglia M; Zenker M
Hum Mol Genet; 2020 Jul; 29(11):1772-1783. PubMed ID: 31108500
[TBL] [Abstract][Full Text] [Related]
15. A Novel SHOC2 Variant in Rasopathy.
Hannig V; Jeoung M; Jang ER; Phillips JA; Galperin E
Hum Mutat; 2014 Nov; 35(11):1290-4. PubMed ID: 25137548
[TBL] [Abstract][Full Text] [Related]
16. The scaffold protein Shoc2/SUR-8 accelerates the interaction of Ras and Raf.
Matsunaga-Udagawa R; Fujita Y; Yoshiki S; Terai K; Kamioka Y; Kiyokawa E; Yugi K; Aoki K; Matsuda M
J Biol Chem; 2010 Mar; 285(10):7818-26. PubMed ID: 20051520
[TBL] [Abstract][Full Text] [Related]
17. Structure of SHOC2-PP1C-RAS Reveals a Mechanism of RAF Activation.
Cancer Discov; 2022 Sep; 12(9):OF1. PubMed ID: 35838404
[TBL] [Abstract][Full Text] [Related]
18. Classical RAS proteins are not essential for paradoxical ERK activation induced by RAF inhibitors.
Lai LP; Fer N; Burgan W; Wall VE; Xu B; Soppet D; Esposito D; Nissley DV; McCormick F
Proc Natl Acad Sci U S A; 2022 Feb; 119(5):. PubMed ID: 35091470
[TBL] [Abstract][Full Text] [Related]
19. M-Ras/Shoc2 signaling modulates E-cadherin turnover and cell-cell adhesion during collective cell migration.
Kota P; Terrell EM; Ritt DA; Insinna C; Westlake CJ; Morrison DK
Proc Natl Acad Sci U S A; 2019 Feb; 116(9):3536-3545. PubMed ID: 30808747
[TBL] [Abstract][Full Text] [Related]
20. The FBXW7-SHOC2-Raptor Axis Controls the Cross-Talks between the RAS-ERK and mTORC1 Signaling Pathways.
Xie CM; Tan M; Lin XT; Wu D; Jiang Y; Tan Y; Li H; Ma Y; Xiong X; Sun Y
Cell Rep; 2019 Mar; 26(11):3037-3050.e4. PubMed ID: 30865892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]